Biolegend, 568804, Biotinylated Recombinant Human SIRPα V2 (carrier-free)
25microg
Catalog Number: 568804
Send an RFQ.
Category
| Source | Biotinylated human SIRPα V2 amino acids Glu31-Arg369 (Accession # P78324) with a C-terminal His and Avi tag was expressed in CHO cells. Human SIRPα V2-Avi tag was site-specifically biotinylated by enzyme BirA. |
|---|---|
| Molecular Mass | The 360 amino acid recombinant protein has a predicted molecular mass of approximately 39.7 kD. The DTT-reduced and non-reduced protein migrate at approximately 50-60 kD in SDS-PAGE. |
| N-terminalSequence Analysis | The predicted N-terminal amino acid is Glu. |
| Purity | > 95%, as determined by Coomassie stained SDS-PAGE. |
| Formulation | 0.22 µm filtered protein solution is in PBS, pH 7.4 |
| Endotoxin Level | Less than 0.1 EU per μg of cytokine as determined by the LAL method |
| Concentration | 25 µg size is bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Storage & Handling |
|---|
| Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at - 20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 μg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles. |
| Activity | Immobilized biotinylated recombinant human SIRPα V2 supports adhesion of human red blood cells in dose-dependent manner. ED50 of this effect is 1.2 – 9.6 µg/mL. |
|---|
| Application | Bioassay |
|---|
| Application Notes | BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are validated in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at [email protected]. |
|---|
| Structure | Monomer |
|---|
| Distribution | Macrophages and dendritic cells |
|---|
| Function | Regulation of leukocyte adhesion and transmigration, T cell activation, macrophage fusion and phagocytosis |
|---|
| Interaction | CD47 expressing cells including tumor cells |
|---|
| Ligand/Receptor | CD47 |
|---|
| Bioactivity | Immobilized biotinylated recombinant human SIRPα V2 supports adhesion of human red blood cells in dose-dependent manner. ED50 of this effect is 1.2 – 9.6 µg/mL. |
|---|
| Cell Type | Dendritic cells, Macrophages |
|---|
| Biology Area | Cell Adhesion, Immuno-Oncology, Innate Immunity, Signal Transduction |
|---|
| Molecular Family | CD Molecules, Soluble Receptors |
|---|
| Antigen References | Van Beek EM, et al. 2005. J Immunol. 12:7781-7. Lee WY, et al. 2007. J Immunol. 11:7741-50. Subramanian S, et al. 2006. Blood. 107:2548-56. Barclay AN. 2009. Current Opinion in Immunology. 21::47-52. Liu Y, et al. 2005. J Biol Chem. 43:36132-40. Takenaka K, et al. 2007. Nat Immunol. 12:1313-23. Veillette A, et al. 2018. Trends Immunol. 39:173-184. Barclay AN, et al. 2014. Annu Rev Immunol. 32:25-50. Murata Y et al. 2018. Cancer Sci. 109:2349-2357. Matozaki T, et al. 2009. Trends Cell Biol. 19:72-80. Feng M ,et al. 2019. Nat Rev Cancer. 19:568-586. Voets, et al. 2019. J Immunother Cancer. 7:340. |
|---|
| Gene ID | 140885 |
|---|
| UniProt | View information about SIRPalpha V2 on UniProt.org |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | SHP substrate 1; SHPS-1, CD172a, Brain Ig-like molecule withtyrosine-based activation motifs (Bit), CD172 antigen-like familymember A, Inhibitory receptor SHPS-1, Macrophage fusionreceptor, MyD-1 antigen |
|---|